Evidence map›Paper›PMID 20670733›Full record

Trial reportThe American journal of medicine2010

No effect of selenium supplementation on serum glucose levels in men with prostate cancer.

Amit M Algotar, Mimi Suzanne Stratton, Steven P Stratton, Chiu-Hsieh Hsu, Frederick R Ahmann

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The American journal of medicine, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Amit M AlgotarArizona Cancer Center, University of Arizona, Tucson, AZ 85724, USA.
Mimi Suzanne Stratton
Steven P Stratton
Chiu-Hsieh Hsu
Frederick R Ahmann
University of Arizona · US

Funding

VITAMIN AP30CA023074 · NCI · UNIVERSITY OF ARIZONA · PI Justin M Snider · 1985 to 2026
$110.2M
PHASE II CHEMOPREVENTION TRIAL OF SE AND PROSTATE CANCERU01CA079080 · NCI · UNIVERSITY OF ARIZONA · PI AHMANN, FREDERICK R · 1998 to 2002
$2.4M
Phase II Chemoprevention Trial of Selenium and Prostate CancerR01CA079080 · NCI · UNIVERSITY OF ARIZONA · PI AHMANN, FREDERICK R · 2005 to 2006
$1.1M
NCI NIH HHS CA023074NCI NIH HHS CA079080NCI NIH HHS P30 CA023074NCI NIH HHS R01 CA079080NCI NIH HHS U01 CA079080
6 · The paper itself

Abstract

backgroundLiterature indicates a relationship between selenium supplementation and risk of diabetes. However, because these data are inconclusive, we investigated the effect of selenium supplementation on serum glucose levels in men with prostate cancer enrolled in a clinical trial testing of the effect of selenium on prostate cancer progression.

methodsSubjects were randomized to receive placebo (n=46), selenium 200 microg/day (n=47), and selenium 800 microg/day (n=47). Serum glucose levels were obtained every 6 months for up to 5 years. Longitudinal analysis was carried out to assess whether rate of change of serum glucose levels was significantly different in the selenium-supplemented groups as compared with placebo. Sensitivity analyses were performed to assess the robustness of findings.

resultsChanges in serum glucose levels during the course of the trial were not statistically significantly different as compared with placebo for the selenium 200 microg/day (P=.56) or selenium 800 microg/day (P=.91) treatment groups.

conclusionThese results do not support a relationship between selenium supplementation and changes in serum glucose levels. Recommendations about selenium supplementation and risk of diabetes will require more definitive studies.

Indexed as

AgedBlood GlucoseDietary SupplementsDisease ProgressionDose-Response Relationship, DrugHumansMaleProstatic NeoplasmsSeleniumTrace ElementsBlood GlucoseSeleniumTrace Elements

Identifiers

PMID20670733
PMCPMC2913148
OpenAlexW2036647797

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.